The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1253-1261

  Feng, Sheau Line Y ^a   Guo, Yan ^a   Factor, Valentina M ^b   Thorgeirsson, Snorri S ^b   Bell, Daphne W ^c   Testa, Joseph R ^c   Peifley, Kimberly A ^a   Winkles, Jeffrey A ^a,d  

^a HOLLAND LABORATORY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MESSENGER RNA; POLYPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CHROMOSOME MAP; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMEDIATE EARLY GENE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER REGENERATION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0033843466     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64996-6     Document Type: Article

References (44)

1. Receptor protein-tyrosine kinases and their signal transduction pathways
2. Serum-and polypeptide growth factor-inducible gene expression in mouse fibroblasts
3. The transcriptional program in the response of human fibroblasts to serum
4. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
5. Identification of FGF-1-inducible genes by differential display
6. Differential display using random hexamer-primed cDNA, motif primers, and agarose gel electrophoresis
7. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration
8. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor-α in hepatic oncogenesis
9. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α
10. Coexpression of c-myc and transforming growth factor-α in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice
11. Mapping small DNA sequences by fluorescence in situ hybridization directly on banded metaphase chromosomes
12. Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents
13. Experimental models for studying the interaction of Kuppfer cells and hepatocytes
14. Continuous subcultivation of epithelial-like cells from normal human tissues
15. Establishment and characterization of a new human hepatocellular carcinoma cell line
16. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines
17. Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: Inhibitory actions of vitamin K
18. Non-random breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines
19. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
20. Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator: Role in HBV pathogenesis
21. Hepatocellular carcinoma
22. Hepatocellular carcinoma
23. The increasing incidence of hepatocellular carcinoma
24. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma
25. Hepatitis viruses and hepatocellular carcinoma
26. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
27. Liver cell lines
28. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma
29. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
30. A novel gene (HIP) activated in human primary liver cancer
31. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: Biological significance and temporospatial distribution
32. Regulation of liver growth: Protooncogenes and transforming growth factors
33. Liver regeneration: Molecular mechanisms of growth control
34. Liver regeneration
35. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
36. Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver
37. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration
38. Transgenic mouse models of hepatocellular carcinoma
39. Transgenic hepatocarcinogenesis in the rat
40. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor-α transgenes
41. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor-α
42. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-myc and transforming growth factor-α in the liver
43. Functional inactivation but not structural mutation of p53 causes liver cancer
44. Identification by targeted differential display of an immediate-early gene encoding a putative serine/threonine kinase